Edesa Biotech, Inc. (EDSA) is a pharmaceutical preparations company incorporated in British Columbia, Canada, listed on the Nasdaq. With a market capitalization of $11 million, Edesa Biotech, Inc. is a micro-cap company. The stock currently trades at $2.28, up 3.56% today, with a 52-week range of $0.72–$2.95.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | — | $-1.27 | +34.2% | |
| 2024 | — | $-1.93 | — | |
| 2023 | — | — | — | |
| 2022 | — | — | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | $-0.57 | $-0.57 | -58.3% | |
| 2015 | $-0.36 | $-0.36 | — | |
| 2014 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-09-30 | 2025-12-12 | 0001171843-25-007914 | SEC ↗ |
| 2024-09-30 | 2024-12-13 | 0001171843-24-006946 | SEC ↗ |
| 2023-09-30 | 2023-12-15 | 0001654954-23-015632 | SEC ↗ |
| 2022-09-30 | 2022-12-16 | 0001654954-22-016633 | SEC ↗ |
| 2021-09-30 | 2021-12-28 | 0001654954-21-013551 | SEC ↗ |
| 2020-09-30 | 2020-12-07 | 0001654954-20-013236 | SEC ↗ |
| 2018-09-30 | 2018-11-30 | 0001144204-18-062614 | SEC ↗ |
| 2017-09-30 | 2017-12-01 | 0001144204-17-061791 | SEC ↗ |
| 2016-09-30 | 2016-12-14 | 0001144204-16-139528 | SEC ↗ |
| 2015-09-30 | 2015-12-14 | 0001144204-15-070753 | SEC ↗ |
| 2014-08-31 | 2014-11-14 | 0001144204-14-068912 | SEC ↗ |